Better brain surgery for high-grade glioma with light
Part of Cancer clinical trials.
This study tests a special imaging device (GLOW400) used during brain surgery for high-grade glioma. The device works with a fluorescent dye (5-ALA) to help the surgeon see the tumor more clearly, which may improve removal of the tumor while protecting healthy brain tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a suspected high-grade glioma (a fast-growing brain tumor) seen on your scans (MRI or CT) and be planning to have surgery to remove it.
- During surgery, a dye called 5-ALA will be given to help the surgeon see the tumor clearly.
- You must be able to understand the study and sign a consent form yourself (in Switzerland, a legal representative cannot sign for you).
- You cannot have a known allergy to 5-ALA or a condition called porphyria (a rare blood disorder).
- You cannot have an uncontrolled health condition that could make surgery risky, and you cannot be a United States citizen.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special imaging tool that helps surgeons see brain tumors more clearly during surgery. It uses a drug called 5-ALA, which makes tumor cells glow, and a camera that captures detailed images to help remove as much tumor as possible while protecting healthy brain tissue.
This trial tests a dye (SBK2-ICG) that makes brain tumors glow during surgery. It's a safety study to see if the dye is safe and works well, which might help surgeons remove brain tumors more completely.
This trial tests if a special dye attached to the immunotherapy drug nivolumab can help surgeons see tumor cells during surgery for high grade glioma. You may join if you are scheduled for surgery and your organs are working well.
This study tests the GLOW800 device which uses a special dye (ICG) to help surgeons see blood flow during brain or reconstructive surgery. It aims to confirm the device works as intended.
This trial tests a technique called fluorescence-enhanced surgery to help surgeons see and remove high-grade gliomas more clearly. It uses a special dye (5-ALA) that makes tumor cells glow during surgery.
This trial tests a dye that makes brain tumor tissue glow under a special light during surgery, helping the surgeon see and remove more of the tumor while sparing healthy brain. It is for people with newly diagnosed high-grade glioma (a fast-growing brain tumor) who are scheduled for their first surgery to remove the tumor.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.